|
Impact of hemoperfusion combined with hemodialysis on the left ventricular function in patients with maintenance hemodialysis
2013, 12 (04):
175-179.
doi: 10.3969/j.issn.1671-4091.2013.04.00
【Abstract】 Objective To investigate whether the combination of maintenance hemodialysis (MHD) with hemoperfusion (HP) improves left ventricular function in MHD patients. Methods This study was a prospective, randomized, controlled clinical trial. Fifty-nine MHD patients were selected and randomly divided into two groups. Group HD was given hemodialysis (HD) 3 times a week, and group HP+HD received HD 2 times a week and HD combined with HP once a week. This study lasted for 6 months. Left ventricular structure and function of the patients were measured by echocardiography before and after the study. Clinical and laboratory data were also collected. Results Before the study, there were no differences in antihypertensive drugs, systolic blood pressure (SBP), diastolic blood pressure (DBP), serum concentrations of CRP, iPTH and β2-MG, and left ventricular mass index (LVMI) between the two groups. At the end of the six months observation, serum β2-MG and LVMI decreased significantly in group HD+HP (P =0.017 and 0.035, respectively), but showed no differences in group HD. There is a positive correlation between serum β2-MG level and LVMI in group HD+HP (P =0.034). Conclusion MHD combined with HP could reduce LVMI in MHD patients, probably due to the better clearance of middle and large molecular uremic toxins. Objective: To investigate whether the combination of maintenance hemodialysis (MHD) with hemoperfusion (HP) could improve the left ventricular function of MHD patients.
Methods: This study was a prospective, randomized, controlled clinical trial. 59 MHD patients were selected and then randomly divided into two groups. Group HD was given HD alone 3 times a week, whereas Group HP+HD received HD alone 2 times a week and the combined treatment of HD with HP once a week. This study was followed up for 6 months and the patients’ left ventricular structure and function was measured by echocardiography before and after the study. The clinical and laboratory data were also collected.
Results: There are no difference in the types of antihypertensive drugs, systolic blood pressure (SBP), diastolic blood pressure (DBP), serum concentration of CRP, iPTH, β2-MG, left ventricular mass index (LVMI) of the two groups before the study. At the end of the 6-months’ observation, the serum level of β2-MG and LVMI of the group HD+HP decreased significantly (P=0.017 and 0.035 respectively) while there is no difference in the group HD. There is a significant correlation between the level of β2-MG and LVMI in the HD and HP group (p=0.034)。
Conclusion: Maintenance hemodialysis combined with hemoperfusion could reduce the LVMI of MHD patients. It may be due to the clearance of middle and large molecular uremic toxins.
Metrics
|